IBDEI3GH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58134,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,58134,1,4,0)
 ;;=4^H40.61X0
 ;;^UTILITY(U,$J,358.3,58134,2)
 ;;=^5005906
 ;;^UTILITY(U,$J,358.3,58135,0)
 ;;=H40.61X2^^272^2901^41
 ;;^UTILITY(U,$J,358.3,58135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58135,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,58135,1,4,0)
 ;;=4^H40.61X2
 ;;^UTILITY(U,$J,358.3,58135,2)
 ;;=^5005908
 ;;^UTILITY(U,$J,358.3,58136,0)
 ;;=H40.61X3^^272^2901^42
 ;;^UTILITY(U,$J,358.3,58136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58136,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,58136,1,4,0)
 ;;=4^H40.61X3
 ;;^UTILITY(U,$J,358.3,58136,2)
 ;;=^5133509
 ;;^UTILITY(U,$J,358.3,58137,0)
 ;;=H40.61X4^^272^2901^39
 ;;^UTILITY(U,$J,358.3,58137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58137,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,58137,1,4,0)
 ;;=4^H40.61X4
 ;;^UTILITY(U,$J,358.3,58137,2)
 ;;=^5005909
 ;;^UTILITY(U,$J,358.3,58138,0)
 ;;=H40.62X1^^272^2901^35
 ;;^UTILITY(U,$J,358.3,58138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58138,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Mild Stage
 ;;^UTILITY(U,$J,358.3,58138,1,4,0)
 ;;=4^H40.62X1
 ;;^UTILITY(U,$J,358.3,58138,2)
 ;;=^5005911
 ;;^UTILITY(U,$J,358.3,58139,0)
 ;;=H40.62X0^^272^2901^38
 ;;^UTILITY(U,$J,358.3,58139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58139,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Unspec Stage
 ;;^UTILITY(U,$J,358.3,58139,1,4,0)
 ;;=4^H40.62X0
 ;;^UTILITY(U,$J,358.3,58139,2)
 ;;=^5005910
 ;;^UTILITY(U,$J,358.3,58140,0)
 ;;=H40.62X2^^272^2901^36
 ;;^UTILITY(U,$J,358.3,58140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58140,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,58140,1,4,0)
 ;;=4^H40.62X2
 ;;^UTILITY(U,$J,358.3,58140,2)
 ;;=^5005912
 ;;^UTILITY(U,$J,358.3,58141,0)
 ;;=H40.62X3^^272^2901^37
 ;;^UTILITY(U,$J,358.3,58141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58141,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,58141,1,4,0)
 ;;=4^H40.62X3
 ;;^UTILITY(U,$J,358.3,58141,2)
 ;;=^5133510
 ;;^UTILITY(U,$J,358.3,58142,0)
 ;;=H40.62X4^^272^2901^34
 ;;^UTILITY(U,$J,358.3,58142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58142,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Left Eye,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,58142,1,4,0)
 ;;=4^H40.62X4
 ;;^UTILITY(U,$J,358.3,58142,2)
 ;;=^5005913
 ;;^UTILITY(U,$J,358.3,58143,0)
 ;;=H40.63X0^^272^2901^33
 ;;^UTILITY(U,$J,358.3,58143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58143,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Unspec Stage
 ;;^UTILITY(U,$J,358.3,58143,1,4,0)
 ;;=4^H40.63X0
 ;;^UTILITY(U,$J,358.3,58143,2)
 ;;=^5005914
 ;;^UTILITY(U,$J,358.3,58144,0)
 ;;=H40.63X1^^272^2901^30
 ;;^UTILITY(U,$J,358.3,58144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58144,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Mild Stage
 ;;^UTILITY(U,$J,358.3,58144,1,4,0)
 ;;=4^H40.63X1
 ;;^UTILITY(U,$J,358.3,58144,2)
 ;;=^5005915
 ;;^UTILITY(U,$J,358.3,58145,0)
 ;;=H40.63X2^^272^2901^31
 ;;^UTILITY(U,$J,358.3,58145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58145,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Moderate Stage
 ;;^UTILITY(U,$J,358.3,58145,1,4,0)
 ;;=4^H40.63X2
 ;;^UTILITY(U,$J,358.3,58145,2)
 ;;=^5005916
 ;;^UTILITY(U,$J,358.3,58146,0)
 ;;=H40.63X3^^272^2901^32
 ;;^UTILITY(U,$J,358.3,58146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58146,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Bilateral,Severe Stage
